Wednesday, November 18, 2026
FDA RECALLClass IINovember 10, 2026

FDA Class II: American Health Packaging Recalls Cyanocobalamin Injection, USP, 1,000 mcg/mL, Rx Only, 25 x 1mL -Multiple-Dose Vi

Affected Product:Cyanocobalamin Injection, USP, 1,000 mcg/mL, Rx Only, 25 x 1mL -Multiple-Dose Vials per carton, Mfg. by: American Regent, Inc., For Bluepoint Laboratories. Carton NDC 68001-542-60; Vial NDC 68001-542-59
Recalling Firm / Manufacturer:American Health Packaging
Reference / Recall Number:D-0173-2027
Distribution Scope:Nationwide in the USA
Executive Summary:

Class II announced by FDA for Cyanocobalamin Injection, USP, 1,000 mcg/mL, Rx Only, 25 x 1mL -Multiple-Dose Vials per carton, Mfg. by: American Regent. Reason: Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination ...

The U.S. Food and Drug Administration (FDA) has posted an official drug enforcement report concerning American Health Packaging.

Product and Classification Details

  • Recall Number: D-0173-2027
  • Classification: Class II
  • Recalling Firm: American Health Packaging
  • Status: Ongoing

Reason for Enforcement Action

Presence of particulate matter:American Regent, Inc. notified BluePoint Pharmaceuticals Laboratories regarding potential glass particle contamination (foreign glass fragment) identified in the product batch.

Distribution Information

Nationwide in the USA

Official notification published per FDA Center for Drug Evaluation and Research (CDER) surveillance databases.
Official Regulatory Docket:Open Agency Docket